celltrion vegzelma permission canada
Scope
Date
~
-
Energy
Land use for SK Ecoplant's wind power venture in Canada approved
The green hydrogen Nujio’qonik project in Canada, a venture that South Korea's SK Ecoplant is taking part in, has secured approval to use go...
Sep 04, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion to release Stelara biosimilar in US from March 2025
South Korean biopharmaceutical company Celltrion Inc. announced on Friday that it has completed a patent agreement with Johnson & Johnson, the m...
Aug 25, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion considers listing holding firm after merger of 3 units
South Korean drug giant Celltrion Group will consider listing its holding company if necessary, after it completes the merger of three affiliates &n...
Aug 24, 2023 (Gmt+09:00)
-
Shipping & Shipbuilding
Hanwha Ocean to raise $1.5 bn to boost warship business
South Korea's Hanwha Ocean Co. will secure 2 trillion won ($1.5 billion) in fresh capital through rights issues, the company said on Wednesday, as t...
Aug 23, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s Vegzelma listed on prescription of 10 private US insurers
South Korea’s Celltrion Healthcare Co. announced on Wednesday that it has signed contracts with 10 insurance providers in the US to boost the ...
Aug 23, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets OK partial approval for phase 3 of biosimilar in Europe
South Korean biopharmaceutical company Celltrion Inc. announced on Tuesday that it has received approval from the European Medicines Agency (EMA) fo...
Aug 22, 2023 (Gmt+09:00)
-
Batteries
EcoPro BM, SK On, Ford to invest $886 mn to build cathode plant in Canada
EcoPro BM Co., South Korea’s leading battery material producer, will invest $886 million jointly with SK On Co. and Ford Motor Co. to build a ...
Aug 18, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion to merge with global sales affiliate by end-2023
South Korean pharmaceutical giant Celltrion Group has begun procedures to merge biopharmaceuticals developer and producer Celltrion Inc. with global...
Aug 17, 2023 (Gmt+09:00)
-
Korean games
Com2us launches RPG game ‘Heir of Light: Eclipse’ in Canada, Indonesia
Com2us Holdings Corp. announced on Wednesday that its new role-playing game (RPG), Heir to Light: Eclipse, is now available on Google Play in ...
Aug 02, 2023 (Gmt+09:00)
-
Batteries
LG Energy Solution expands cobalt supply deal with Canada’s Electra
LG Energy Solution Ltd. has signed a long-term contract to receive additional refined cobalt from Electra Battery Materials Corp. in Canada, in a mo...
Jul 25, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Biopharmaceuticals gets OK to sell epilepsy drug in Canada
South Korea's SK Biopharmaceuticals has received approval in Canada to sell its new epilepsy drug Cenobamate under the product name Xcopri. Having e...
Jul 12, 2023 (Gmt+09:00)
-
Carbon neutrality
Samsung Biologics, Celltrion pledge major CO2 cuts
South Korea’s No. 1 biopharmaceutical company Samsung BioLogics Co. and No. 2 Celltrion Inc. produced higher CO2 emissions last year than in 2...
Jul 10, 2023 (Gmt+09:00)
-
Batteries
Deal reached on LG-Stellantis battery plant subsidy; construction resumes
All construction work at a battery joint venture in Canada between South Korea’s LG Energy Solution Ltd. and multinational automaker Stellanti...
Jul 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare launches Humira biosimilar Yuflyma in US
South Korean biopharmaceutical company Celltrion Healthcare on Monday said it launched the day before on the US market Yuflyma, a biosimilar of the ...
Jul 04, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for approval in US for eye treatment biosimilar
South Korean biopharmaceutical company Celltrion Inc. on Friday said it applied for approval from the US Food and Drug Administration (FDA) for CT-P...
Jun 30, 2023 (Gmt+09:00)
-
Leadership & Management
POSCO’s Choi traverses Canada, US to pitch for battery material projects
Choi Jeong-woo, chairman of South Korea’s largest steel group POSCO, is crisscrossing Canada and the US to meet with politicians and business ...
Jun 28, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion puts Takeda’s assets up for sale after 3 years
South Korea’s Celltrion Inc. has put its Japanese Takeda Pharmaceutical Co.'s primary care assets acquired in 2020 on sale as the biosimilar g...
Jun 18, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Biopharm’s Cenobamate gets nod in Canada, to boost US sales
South Korea’s SK Biopharmaceuticals Co. has obtained the sales approval for its antiepileptic treatment Cenobamate in Canada, paving the way f...
Jun 15, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion wins phase 3 IND approval for Ocrevus biosimilar in US
South Korea's biopharmaceutical company Celltrion Inc. announced that it received on Thursday approval from the US Food and Drug Administration (FDA...
Jun 15, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion to expand biosimilar portfolio to 11 by 2025
South Korea's biopharmaceutical company Celltrion Inc. announced on Tuesday that it plans to beef up its portfolio by applying for regulatory approv...
Jun 13, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion to develop Humira biosimilar oral medication with US firm
South Korea's biopharmaceutical company Celltrion Inc. announced on Monday that it has signed a contract with the US biotech firm Rani Therapeutics ...
Jun 05, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s Remsima SC praised in Europe as preferred biosimilar
MILAN – South Korea's biopharmaceutical company Celltrion Inc. is known in Europe for its biosimilar products such as autoimmune disease treat...
Jun 02, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion unveils phase 1 clinical data of Actemra biosimilar in Europe
South Korean biosimilar giant Celltrion Inc. revealed on Wednesday the highly anticipated clinical phase 1 data for its Actemra biosimilar, CT-P47, ...
May 31, 2023 (Gmt+09:00)
-
Bio & Pharma
BIO USA 2023 to draw S.Korean biotech leaders, startups
More than 500 South Korean companies from top business groups to AI-based biotech startups are slated to attend the Bio International Convention 202...
May 30, 2023 (Gmt+09:00)
-
Batteries
POSCO Future M-GM JV to receive investment from Canadian gov’t
POSCO Future M Co., a unit of South Korean steel giant POSCO Holdings Inc., revealed on Monday that Ultium CAM, its joint venture with General Motor...
May 30, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets FDA approval for Humira biosimilar CT-P17
South Korean biopharmaceutical company Celltrion Inc. announced on Wednesday that it has obtained product approval from the US Food and Drug Adminis...
May 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare launches Remsima SC in Brazil
South Korean biopharmaceutical company Celltrion Healthcare Co. revealed on Monday its introduction of Remsima SC, a treatment for autoimmune diseas...
May 22, 2023 (Gmt+09:00)
-
Batteries
Resumption of LG Energy Solution's JV in Canada gets green light
South Korea’s LG Energy Solution Ltd. has received the green light to resume construction of an electric-vehicle battery joint venture in Ca...
May 22, 2023 (Gmt+09:00)
-
Energy
SK Ecoplant to join Canada's $4.5 bn green hydrogen project
South Korea’s SK Ecoplant Co. on Wednesday signed an agreement to join the first-stage, $4.5 billion construction of green hydrogen and ammoni...
May 17, 2023 (Gmt+09:00)
-
Batteries
S.Korea, Canada to bolster key minerals supply partnership
South Korea and Canada will make close cooperation to strengthen their supply chains of critical minerals such as uranium and nickel, key materials ...
May 17, 2023 (Gmt+09:00)